ORTHOTOPIC LIVER-TRANSPLANTATION IN DOGS RECEIVING FK-506

被引:0
|
作者
TODO, S [1 ]
PODESTA, L [1 ]
CHAPCHAP, P [1 ]
KAHN, D [1 ]
PAN, CE [1 ]
UEDA, Y [1 ]
OKUDA, K [1 ]
IMVENTARZA, O [1 ]
CASAVILLA, A [1 ]
DEMETRIS, AJ [1 ]
MAKOWKA, L [1 ]
STARZL, TE [1 ]
机构
[1] UNIV PITTSBURGH,UNIV HLTH CTR,DEPT PATHOL,PITTSBURGH,PA 15213
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:64 / 67
页数:4
相关论文
共 50 条
  • [41] FK-506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
    STARZL, TE
    TODO, S
    FUNG, J
    DEMETRIS, AJ
    VENKATARAMMAN, R
    JAIN, A
    LANCET, 1989, 2 (8670): : 1000 - 1004
  • [42] GASTROINTESTINAL AND METABOLIC PROBLEMS ASSOCIATED WITH IMMUNOSUPPRESSION WITH EITHER CYA OR FK-506 IN LIVER-TRANSPLANTATION
    VANTHIEL, DH
    IQBAL, M
    JAIN, A
    FUNG, J
    TODO, S
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (01) : 37 - 40
  • [43] USE OF PROGRAF (FK-506) AS RESCUE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION
    KLINTMALM, GBG
    GOLDSTEIN, R
    GONWA, T
    WIESNER, RH
    KROM, RAF
    SHAW, BW
    STRATTA, R
    ASCHER, NL
    ROBERTS, JW
    LAKE, J
    BUSUTTIL, RW
    MCDIARMID, S
    ESQUIVEL, CO
    NAKAZATO, P
    MARSH, JW
    WOODLE, ES
    KALAYOGLU, M
    DALESSANDRO, AM
    PIRSCH, JD
    MILLER, C
    SCHWARTZ, M
    LEWIS, WD
    MONACO, AP
    JENKINS, RL
    EMOND, JC
    THISTLETHWAITE, JR
    WHITINGTON, PF
    STEINMULLER, DR
    FITZSIMMONS, WE
    LAWRENCE, I
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 679 - 688
  • [44] NEPHROTOXIC EFFECTS OF PRIMARY IMMUNOSUPPRESSION WITH FK-506 AND CYCLOSPORINE REGIMENS AFTER LIVER-TRANSPLANTATION
    PORAYKO, MK
    TEXTOR, SC
    KROM, RAF
    HAY, JE
    GORES, GJ
    RICHARDS, TM
    CROTTY, PH
    BEAVER, SJ
    STEERS, JL
    WIESNER, RH
    MAYO CLINIC PROCEEDINGS, 1994, 69 (02) : 105 - 111
  • [45] INFECTIONS DURING A RANDOMIZED TRIAL COMPARING CYCLOSPORINE TO FK-506 IMMUNOSUPPRESSION IN LIVER-TRANSPLANTATION
    KUSNE, S
    FUNG, J
    ALESSIANI, M
    MARTIN, M
    TORRECISNEROS, J
    IRISH, W
    ONDICK, L
    JAIN, A
    ABUELMAGD, K
    TAKAYA, S
    TODO, S
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (01) : 429 - 430
  • [46] LIVER-TRANSPLANTATION OF AMERICAN VETERANS UNDER FK-506 IMMUNOSUPPRESSION - A PRELIMINARY-REPORT
    MIELES, LA
    FUNG, JJ
    YOKOYAMA, I
    MCCAULEY, J
    SINGH, N
    TODO, S
    GORDON, RD
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3016 - 3018
  • [47] FK-506 IN LIVER-TRANSPLANTATION - CORRELATION OF WHOLE-BLOOD LEVELS WITH EFFICACY AND TOXICITY
    SCHWARTZ, M
    HOLST, B
    FACKLAM, D
    BUELL, D
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1107 - 1107
  • [48] A RANDOMIZED TRIAL OF PRIMARY LIVER-TRANSPLANTATION UNDER IMMUNOSUPPRESSION WITH FK-506 VS CYCLOSPORINE
    FUNG, J
    ABUELMAGD, K
    JAIN, A
    GORDON, R
    TZAKIS, A
    TODO, S
    TAKAYA, S
    ALESSIANI, M
    DEMETRIS, A
    BRONSTER, O
    MARTIN, M
    MIELES, L
    SELBY, R
    REYES, J
    DOYLE, H
    STIEBER, A
    CASAVILLA, A
    STARZL, T
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 2977 - 2983
  • [49] GLUCOSE-METABOLISM FOLLOWING LIVER-TRANSPLANTATION AND IMMUNOSUPPRESSION WITH CYCLOSPORINE-A OR FK-506
    SENNINGER, N
    GOLLING, M
    DATSIS, K
    SIDO, B
    HERFARTH, C
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1127 - 1128
  • [50] NEUROTOXICITY AFTER ORTHOTOPIC LIVER-TRANSPLANTATION - A COMPARISON BETWEEN CYCLOSPORINE AND FK506
    MUELLER, AR
    PLATZ, KP
    BECHSTEIN, WO
    SCHATTENFROH, N
    STOLTENBURGDIDINGER, G
    BLUMHARDT, G
    CHRISTE, W
    NEUHAUS, P
    TRANSPLANTATION, 1994, 58 (02) : 155 - 170